Search for Clinical Trial Results
Cutaneous T-cell Lymphoma - 27 Studies Found
Status | Study |
Recruiting |
Study Name: FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Condition: Cutaneous T-Cell Lymphoma Date: 2015-05-13 Interventions:
|
Active, not recruiting |
Study Name: Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma Condition: Cutaneous T-Cell Lymphoma (CTCL) Date: 2014-08-06 Interventions: Drug: SHAPE topical gel Other Name: SHP-141 |
Completed |
Study Name: Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Condition: Cutaneous T-cell Lymphoma (CTCL), Date: 2007-07-12 Interventions: Drug: Forodesine 200 mg 2 x 100mg tablets once daily |
Not yet recruiting |
Study Name: A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma Condition: Cutaneous T-cell Lymphoma (CTCL) Date: 2015-11-24 Interventions:
|
Recruiting |
Study Name: Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma Condition:
Date: 2016-02-04 Interventions: Drug: E7777 |
RECRUITING |
Study Name: HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL Condition: Cutaneous T-Cell Lymphoma/Mycosis Fungoides Date: 2024-05-19 Interventions: HyBryte is synthetic hypericin formulated as a 0.25% hypericin ointment. |
RECRUITING |
Study Name: A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides Condition: Cutaneous T-cell Lymphoma Date: 2024-05-19 Interventions: Orally every day starting at the dose of 150 mg/day flat dose.At Day 15, if the treatment is tolerated, patients will escalate the dose of |